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Background: Pseudomonas fluorescens strain MFE01 secretes in abundance two Hcp proteins (haemolysin
co-regulated proteins) Hcp1 and Hcp2, characteristic of a functional type 6 secretion system. Phenotypic studies
have shown that MFE01 has antibacterial activity against a wide range of competitor bacteria, including
rhizobacteria and clinically relevant bacteria. Mutagenesis of the hcp2 gene abolishes or reduces, depending on
the target strain, MFE01 antibacterial activity. Hcp1, encoded by hcp1, may also be involved in bacterial competition.
We therefore assessed the contribution of Hcp1 to competition of P. fluorescens MFE01 with other bacteria, by
studying MFE01 mutants in various competitive conditions.
Results: Mutation of hcp1 had pleiotropic effects on the MFE01 phenotype. It affected mucoidy of the strain and its
motility and was associated with the loss of flagella, which were restored by introduction of plasmid expressing
hcp1. The hcp1 mutation had no effect on bacterial competition during incubation in solid medium. MFE01 was
able to sequester another P. fluorescens strain, MFN1032, under swimming conditions. The hcp2 mutant but not the
hcp1 mutant conserved this ability. In competition assays on swarming medium, MFE01 impaired MFN1032
swarming and displayed killing activity. The hcp2 mutant, but not the hcp1 mutant, was able to reduce MFN1032
swarming. The hcp1 and hcp2 mutations each abolished killing activity in these conditions.
Conclusion: Our findings implicate type 6 secretion of Hcp1 in mucoidy and motility of MFE01. Our study is the
first to establish a link between a type 6 secretion system and flagellin and mucoidy. Hcp1 also appears to
contribute to limiting the motility of prey cells to facilitate killing mediated by Hcp2. Inhibition of motility
associated with an Hcp protein has never been described. With this work, we illustrate the importance and
versatility of type 6 secretion systems in bacterial adaptation and fitness.
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Mucoidy, ExopolysaccharidesBackground
Environmental bacteria are in perpetual war against sev-
eral competitors, and thus require weapons to conquer
new territory. The type 6 secretion system (T6SS) of
Gram-negative bacteria is an effector translocation appar-
atus resembling an inverted bacteriophage puncturing
device [1-3]. It is involved in a broad variety of functions,* Correspondence: annabelle.merieau@univ-rouen.fr
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unless otherwise stated.including antibacterial activity [4,5] and bacterial commu-
nication [6]. For example, Proteus mirabilis uses the killing
activity of T6SS for self-recognition: this T6SS seems to be
activated when opposing P. mirabilis swarms meet. The
result of its action is a visible boundary called the Dienes
line [7,8].
The T6SS machinery comprises at least 13 proteins,
the core components, and sometimes, additional pro-
teins [9,10]. Some of the core component proteins can
affect systems other than T6SS. Hcp proteins, extracellu-
lar components of this secretion machinery, are released. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,















Figure 1 Hcp secretion and mucoid phenotype in P. fluorescens
strains. A: Mucoidy was assessed on LB agar at 28°C. +: mucoid, −:
non mucoid. B: Mucoidy at 28°C or 37°C of MFE01. +: mucoid, −:
non mucoid. The images shown are representative of three assays.
C: Concentrated supernatants of cultures in late exponential growth
phase, grown at 28°C or 37°C, were analysed by SDS-PAGE (15%
separation gel) and Coomassie staining. Bands (indicated by arrows)
with an approximate molecular mass of 21 kDa were observed in
MFE01 and MFE07 supernatants at 28°C. Mass spectrometry identified
these major supernatant proteins as Hcp proteins.
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a functional T6SS apparatus [11]. Silverman and col-
leagues demonstrated that P. aeruginosa Hcp are not
only structural proteins but also play a crucial role as
chaperone and receptor for T6SS effectors. Various Hcp
proteins transport their own effectors and this effector
selection by Hcp seems to be specific [12].
The diversity of T6SS regulation reflects the vast array
of its functions. The P. aeruginosa H1-T6SS gene cluster
exhibits posttranscriptional regulation involving two sen-
sor kinases, RetS and LadS [13-15]. High concentrations
of synthetic c-di-GMP have negative effects on sensor
kinase RetS, leading to P. aeruginosa H1-T6SS being
turned on [16]. It is likely that a similar regulatory path-
way controls the expression of P. protegens Pf-5 and P.
syringae pv. syringae T6SS gene clusters [17,18]. How-
ever, T6SS regulation involves systems that regulate
other genes suggesting regulatory cross-talk between
T6SS and other virulence factors.
Environmental bacteria are often surrounded by an
extracellular matrix, forming a protective capsule called
the glycocalyx [19]. This extracellular matrix is generally
composed of bacterial exopolysaccharides (EPS). EPS are
involved in a variety of functions, including microcolony
formation, protection against bacteriophages and mucoid
phenotypes. The mucoid phenotype of Pseudomonas sp. is
believed to be a global adaptive stress response to adverse
environmental conditions [20,21]. It is characterized by
overproduction of EPS alginate leading to shiny, raised
and opaque colonies. The mucoid phenotype is a major
factor contributing to P. aeruginosa infection in cystic
fibrosis (CF) patients [22,23] but is unstable in vitro [24].
Some P. aeruginosa CF isolates acquire a mucoid pheno-
type through mutation of the anti-sigma factor MucA, a
negative regulatory factor that sequesters AlgU, a positive
regulator of alginate production [22,25]. A proteomic
study by Rao and coworkers found that mucoid P. aeru-
ginosa strains do not express T6SS genes [26]. Unlike P.
aeruginosa, some Vibrio cholerae strains are mucoid and
have an active T6SS [27]. Some environmental P. fluores-
cens strains produce alginate or neutral and amino sugars
which give a mucoid phenotype [28,29]. The P. fluorescens
mucoid phenotype, like that in P. aeruginosa, was re-
ported to be unstable [29]. The mucoid phenotype can
occur following mutation of the negative regulator of the
alginate biosynthetic operon, muc [30]. We previously
characterized the strain MFE01, a mucoid environmental
P. fluorescens isolate. It constitutively secretes two charac-
teristic T6SS proteins at 28°C: Hcp1 and Hcp2. It also ex-
erts antibacterial activity during contact on a solid surface
with competitive bacteria; this activity is associated with
Hcp2 [31]. The aim of this work was to study the role of
Hcp1 and the link between T6SS and the mucoid pheno-
type of MFE01.Results and discussion
Some mucoid P. fluorescens strains secrete Hcp abundantly
The phenotypes of four P. fluorescens strains were obser-
ved after growth on LB agar plates at 28°C. Environmen-
tal strains MFE01 [31] and MFE07 (this study) had a
stable shiny aspect, characteristic of mucoid pheno-
types at 28°C. Skin strain MFP05 [32] and clinical strain
MFN1032 [33] did not have a mucoid phenotype at this
temperature (Figure 1A and B).
MucA is a negative regulator of the mucoid phenotype
[22] in Pseudomonas species. We introduced the mucA
gene of the Pseudomonas protegens strain Pf-5 (previously
described as a P. fluorescens strain) [34] into MFE01. The
expression of mucA did not switch-off mucoidy at 28°C,
suggesting that the mucoid phenotype of MFE01 is not
due to a mutation of the mucA gene or is MucA inde-
pendent (Figure 1A). Scanlan and Buckling showed that
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Figure 2 Effects of hcp1 and hcp2 mutations on mucoid
phenotype. Representative images of mucoidy of MFE01, MFE01Δhcp1,
MFE01Δhcp2, MFE01Δhcp1+pPSV35 and MFE01Δhcp1+hcp1 at 28°C on
LB agar (n = 3). +: mucoid, −: non mucoid.
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nisms of this phenotype remain unknown, they do not in-
clude mutations at many of the loci commonly reported
to be involved in mucoid conversion, including mucA and
algU. They also demonstrated that lytic phage exerts a se-
lection pressure by selecting the mucoid phenotype [29].
We prepared supernatants of cultures of mucoid P.
fluorescens strains MFE01 and MFE07 and found that
these strains secreted large amounts of proteins identi-
fied as Hcp by Mass Spectroscopy (MS) (Figure 1C).
The spot for the protein secreted by MFE01 matched
significantly with gi: 398989489 (T6SS effector, Hcp1 fam-
ily from Pseudomonas sp GM24) with a score of 120 for a
score threshold of 84. The spot for the protein secreted
by MFE07 spot matched significantly with gi:77458272
(hypothetical protein Pfl01_2045 from Pseudomonas
fluorescens Pf0-1, Hcp1 family) with a score of 65 for a
score threshold of 54. The non-mucoid P. fluorescens
strains MFP05 and MFN1032 did not secrete detectable
amounts of Hcp proteins into the extracellular medium.
The optimal growth temperature of MFE01 is 28°C but
it can grow at 37°C. Clearly visible at 28°C, the mucoid
phenotype and Hcp secretion were both switched off at
37°C, suggesting a common regulation of these two phe-
notypes (Figure 1B,C).
Unterweger and colleagues observed a correlation be-
tween the mucoid phenotype and Hcp secretion in V.
cholerae smooth strains [27]. Sigma-54 controls T6SS
genes transcription, so they introduced vasH, encoding a
sigma-54 activator protein, into rough (non mucoid) V.
cholera strains impaired in Hcp secretion: the expression
of vasH restored the mucoid phenotype, but not the
Hcp secretion. However, vasH can activate transcription
of genes other than T6SS genes via sigma-54 [35,36]
suggesting that the correlation between mucoidy and
T6SS in V. cholerae may be due to a common regulation
system.
Hcp1 of P. fluorescens MFE01 is involved in mucoid
phenotype
We constructed hcp mutants, and found that the hcp1
mutation (MFE01Δhcp1 strain) lead to the loss of mucoidy
at 28°C whereas the hcp2 mutation (MFE01Δhcp2 strain)
did not affect the mucoid phenotype (Figure 2). The
introduction of a plasmid carrying the hcp1 gene into
MFE01Δhcp1 (MFE01Δhcp1+hcp1 strain) restored the
wild-type phenotype, suggesting a direct link between
hcp1 expression and mucoidy. We analysed and com-
pared the extracellular matrices (ECM) of MFE01 and
MFE01Δhcp1. The mucoid phenotype is a consequence
of exopolysaccharide (EPS) accumulation [37], so we de-
termined ECM sugar composition by Gas–liquid Chro-
matography (GLC). No significant difference between
MFE01 and MFE01Δhcp1 was observed concerning theproportion of characteristic sugars of the Pseudomonas
EPS (rhamnose, mannose, galactose and glucose; Figure 3A).
Thus, MFE01Δhcp1 is able to secrete an EPS similar to
that produced by MFE01. Nevertheless, the MFE01 ECM
contained twice as much EPS as the MFE01Δhcp1 ECM
suggesting that the loss of the mucoid phenotype was a
consequence of less EPS accumulation (Figure 3B). In
Pseudomonas aeruginosa, biofilm formation and T6SS ex-
pression are negatively regulated by the sensor RetS and
retS mutants produce a hyperbiofilm phenotype [16]. Bio-
film formation by MFE01 and mutants was then assayed.
The moderate biofilm biovolume was not significantly dif-
ferent between MFE01 and MFE01Δhcp1 or MFE01Δhcp2
mutants (Figure 3C). These findings indicate that mucoid
phenotype and biofilm formation are not co-regulated by
T6SS in MFE01.
ECM protein fractions from supernatants of MFE01,
MFE01Δhcp1 and MFE01Δhcp1+hcp1 were studied by
SDS-PAGE (Figure 4A). Proteins of approximate molecu-
lar mass of 38 kDa were present in ECM extracts from
MFE01 and MFE01Δhcp1+hcp1 but not in MFE01Δhcp1.
MS identified these 38 kDa proteins as flagellin proteins:
they matched significantly with flagellin from Pseudo-
monas moraviensis (gi: 515142380) with a score of 94 for
a score threshold of 86. Thus, the mucoid phenotype ap-
pears to involve the accumulation of both EPS and flagel-
lin in ECM, which are perturbed by hcp1 deletion. This
was unexpected because the literature generally reports an
inverse cross-talk between the mucoid phenotype and
flagellar assembly. For example, the alternative sigma fac-
tor, σ22 (synonym AlgT or AlgU), is a positive regulator of
alginate biosynthesis and a negative regulator of flagellum
biosynthesis [38].
P. fluorescens MFE01 Hcp1 is involved in motility
We examined motility of our various strains to eluci-
date the relation between flagellin accumulation in the
ECM and flagellum functionality. MFE01, MFE01Δhcp1,
MFE01Δhcp2, MFE01Δhcp1+pPSV35 (empty vector con-
























































































































































Figure 3 Analysis of the sugar composition of the extracellular matrix and effect of hcp1 and hcp2 mutations on biofilm biovolume.
A: Relative quantity of major sugars (Rha = Rhamnose, Man =Mannose, Gal = Galactose and Glc = Glucose) determined by gas chromatography in
extracellular matrix (ECM) of MFE01 and MFE01Δhcp1. Values are mean results of four independent experiments, and the error bars represent
standard error of the mean. Strains were compared pairwise by non-parametric Mann–Whitney two-tailed tests. ns: no significant difference.
B: Gas chromatographic determinations of the absolute quantity of exopolysaccharides (EPS) in the extracellular matrix (ECM) of MFE01 and
MFE01Δhcp1. Values are mean results of four independent experiments and the error bars represent standard error of the mean. Strains were
compared pairwise by non-parametric Mann–Whitney two-tailed tests. *p-value <0.05. C: Biovolume of biofilms. The biofilms were grown on glass
surface at 28°C for 48 h under a flow of LB medium. Biovolumes were obtained by COMSTAT analyses. Values are mean results of at least five
independent experiments and the error bars represent standard error of the mean. Statistical analyses were performed using Non-parametric
Mann–Whitney Tests (two tailed). ns means no significant difference in biovolume (p-value >0.05) relative to the MFE01 biofilm biovolume assay.
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was restored by hcp1 introduction in trans. The restor-
ation of wild-type phenotype in MFE01Δhcp1+hcp1 is in-
consistent with a possible polar effect of the hcp1 deletion
(Figure 4B).
The type 3 secretion system is related to the flagellum
[39], but little is known about the relation between T6SS














Figure 4 Effect of hcp1 and hcp2 mutations on flagellin secretion into
the ECM of MFE01, MFE01Δhcp1 and MFE01Δhcp1+hcp1 were analysed by
mass ≈ 38 kDa, indicated by the arrows, were observed at the growth temp
(n = 3). Molecular weight markers are indicated. B: Swimming assay on LB i
motile but MFE01Δhcp1 and MFE01Δhcp1+ pPSV35 (empty plasmid used aT6SS protein, is involved in motility [40]. IcmF is an
inner-membrane protein of the T6SS found in numerous
pathogens, and has been implicated in intracellular
multiplication inside host cells [41,42]. In an avian
pathogenic E. coli, icmF mutation impaired motility [43];
the authors indicate that this contrasts with other mu-
tants in T6SS genes, notably clpV and hcp, which had no
motility defects. Their findings suggest that the motilityMFE01 hcp1 
MFE01 hcp1+pPSV35 
MFE01 01 hcp2 
MFE01 hcp1+hcp1 
the extracellular matrix and on motility. A: Protein fractions from
SDS-PAGE and Coomassie staining. Bands with approximate molecular
erature of 28°C and were identified as flagellin proteins by MALDI-TOF
n 0.3% agar at 28°C. MFE01, MFE01Δhcp2 and MFE01Δhcp1+hcp1 were
s control) were non motile (n = 3).
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defect of motility because of a non-functional T6SS.
IcmF was somehow involved in flagellar regulation. The
restoration of the motility of MFE01Δhcp1 by hcp1
introduction in trans implies that the function of T6SS
associated to hcp1 expression is directly involved in mo-
tility in this strain.
The hcp1 mutant of P. fluorescens MFE01 retains virulence
toward competitor bacteria
The Hcp concentration was slightly lower in the super-
natant of MFE01Δhcp1 than that of the wild-type
MFE01 at 28°C (Figure 5A). This is consistent with our
previous observations [31]: most of the Hcp secreted by
MFE01 is produced from the expression of the hcp2
gene. We have also demonstrated that MFE01 has a kill-
ing activity against various Gram-negative bacteria on
solid medium. MFE01Δhcp2 reduced prey cell popula-
tions, but significantly less than MFE01 indicating that
Hcp2 contributes to the killing activity, and that another
factor is also involved. To determine whether Hcp1
could be this other factor, we co-cultured mutant
MFE01Δhcp1 and the prey MFN1032 on a filter on solid
media for 4h at 28°C. There was no significant difference
of the MFN1032 population between the co-culture with
wild-type MFE01 and the co-culture with MFE01Δhcp1
(Figure 5B). Thus, Hcp1 was not the key factor in this


































Figure 5 Hcp secretion and killing activity of P. fluorescens MFE01 an
MFE01Δhcp1 cultures were analysed by SDS-PAGE and Coomassie staining. B
indicated by the arrow, were observed at a growth temperature of 28°C. MW
assays were performed. Prey cells (MFN1032 carrying pSMC21-gfp) were or w
MFE01Δhcp1Δhcp2 and MFE01Δhcp2; after 4 h at 28°C, MFN1032 cfu were co
* Indicates a significant difference in MFN1032 cfu (p-value <0.05) relative to t
a significant difference in MFN1032 cfu (p-value <0.05) relative to the MFN103Whereas, the MFE01Δhcp2 mutant had significantly less
antibacterial activity than MFE01 and MFE01Δhcp1. The
double mutant, MFE01Δhcp1Δhcp2, was even less bac-
tericidal than MFE01Δhcp2 but nevertheless reduced the
MFN1032 population. Another system independent of
Hcp1 and Hcp2 seems to be involved in killing activity.
P. fluorescens MFE01 inhibits the motility of P. fluorescens
strain MFN1032
The killing activity mediated by T6SS during swarming
in P. mirabilis involves self-recognition (the Dienes ef-
fect), and we therefore studied the behaviour of MFE01
in conditions permitting its motility [7,8]. In swimming
conditions (in 0.3% agar), P. fluorescens MFN1032 was
spotted into the centre of a ring formed by MFE01 or its
mutants (Figure 6A). MFE01, MFE01Δhcp1+hcp1 and
MFE01Δhcp2 inhibited MFN1032 motility, but swim-
ming MFN1032 spread through the MFE01Δhcp1 and,
MFE01Δhcp1+pPSV35 mutants (Figure 6B). The hcp1
mutation thus abolished MFE01 confining MFN1032.
Introduction of the native hcp1 gene in trans restored
the inhibitory activity on MFN1032 swimming. Thus, in
these swimming conditions, hcp1 expression seems re-
quired for P. fluorescens MFE01 to control the swim-
ming of P. fluorescens MFN1032. In these conditions,
MFE01Δhcp1 lacked motility whereas MFE01 was motile
(Figure 4B). The confinement of MFN1032 could be









































d derivatives strains. A: Concentrated supernatants of MFE01 and
ands with a molecular mass similar to that of an Hcp protein (≈20 kDa),
M: molecular weight markers are indicated. B: Quantitative co-culture
ere not mixed at ratio of 1:5 with P. fluorescens MFE01, MFE01Δhcp1,
unted (n = 4, the error bars represent standard error of the mean).
he MFN1032/MFE01 assay; ns means no significant difference. ♦ indicates
2 alone control assay.
Figure 6 Effects of P. fluorescens MFE01 and its mutants on competitive bacteria. A: Schematic drawing of the assay: P. fluorescens
MFN1032 was inoculated into the centre of a ring formed by MFE01 or a mutant on LB medium in 0.3% agar. On this medium MFN1032 and
ME01 can swim. B: Swimming of MFN1032 in competition with MFE01 or mutants. Results after incubation at 28°C, 24 h. The images shown are
representative of three assays. C: Co-cultures were performed on swarming medium (LB in 0.6% agar) at 28°C, 24h. On this medium MFN1032 can
swarm but ME01 cannot. Prey cells (MFN1032) were or were not mixed with P. fluorescens MFE01 or its derivatives at ratio 1:5. The images shown
are representative of three assays. D: Quantitative black histograms represent survival of MFN1032 and white squares the MFN1032 swarm diameter
(n = 4, error bars represent standard error of the mean). * Indicates a significant difference of the MFN1032 cfu (p-value <0.05) relative to the MFN1032/
MFE01 assay. ns: no significant difference.
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not form this barrier.
So we therefore conducted co-cultures overnight on
0.6% LB agar, conditions allowing the swarming of
MFN1032. On these plates, MFE01 and mutants were
unable to swarm because MFE01 lacks surfactantsessential for P. fluorescens swarming [44]. MFE01 and
MFE01Δhcp2 clearly inhibited MFN1032 swarming,
whereas MFE01Δhcp1 and MFE01Δhcp1Δhcp2 had much
less effect on MFN1032 swarming (Figure 6C,D). This
indicates that the inhibition of motility observed was
not due to MFE01 or its derivatives forming a physical
Decoin et al. BMC Microbiology  (2015) 15:72 Page 7 of 12barrier. Also, diameter of the MFN1032 swarming was
reduced, albeit to a lesser extent, by the double mutant
MFE01Δhcp1Δhcp2 providing further evidence for an-
other unidentified inhibitory factor. These experiments
are uninformative about whether the decrease in swarming
diameter is due to a killing activity or an immobilization
activity.
We consequently assayed the bactericidal activity of
MFE01 and its mutants by counting MFN1032 cells in
each swarming condition (Figure 6D). The MFN1032
population underwent 5-logs drops after co-culture with
wild-type MFE01. Co-culture with MFE01Δhcp1 and
MFE01Δhcp2 did not significantly decrease the MFN1032
population. We assumed that when co-cultured with
MFE01Δhcp1, MFN1032 cells could swarm and thereby
escape from the killing activity mediated by Hcp2,
which requires close contact. When in co-culture with
MFE01Δhcp2, MFN1032 could not be able to escape
but the killing activity is abolished by hcp2 mutation.
In antibacterial activity assays on solid media (Figure 5B),
the MFN1032 cells were immobilized on a filter, and
therefore unable to escape the killing activity of the hcp1
mutant.
These results suggest that MFE01 needs Hcp1 and
Hcp2 to kill MFN1032 in conditions of motility: Hcp1
could reduce the motility of prey cells and thereby facili-
tate killing by Hcp2.Figure 7 Phenotypes of the MFE01ΔtssC mutant. A: Swimming assay o
motile contrary to MFE01Δhcp1 and MFE01ΔtssC strains (n = 3). B: Represen
28°C, 24 h (n = 3). +: mucoid, −: non mucoid. C: Effects of P. fluorescens MF
were performed on LB medium supplemented with X-Gal (40 μg/ml) at 28
were not mixed with P. fluorescens MFE01 or its derivatives at ratio 1:1. Blue
representative of three assays.Phenotypes assigned to Hcp1 and Hcp2 are associated to
a T6SS
Analysis of MFE01 draft genome is under way. Prelimin-
ary results indicated that this genome contains only one
T6SS cluster exhibiting all core component genes but
hcp genes. The two hcp genes, hcp1 and hcp2, are separ-
ately located outside this cluster and are associated with
vgrG genes. Into this unique T6SS we identified a gene
coding for a putative protein corresponding to a protein
member of EvpB/VC_A108 family (TIGR03355). This
putative protein matched with the WP_016772499.1
sequence (MULTISPECIES: type VI secretion protein
[Pseudomonas], with 99% identity and coverage of
100%). These proteins are described as T6SS needle
sheath proteins TssC and are essential components of
this system. MFE01ΔtssC, a mutant disrupted in this
T6SS core component gene, was non motile in swim-
ming conditions and non-mucoid at 28°C as well as
MFE01Δhcp1 (Figure 7A and B) whereas MFE01Δhcp2
conserved the wild type phenotype (mucoid and motile).
During co-culture on LBG containing X-gal at 28°C
with E.coli containing pUC19 (E.colipUC19), MFE01Δhcp2
and MFE01ΔtssC allowed E.colipUC19 growth (blue spots)
whereas MFE01Δhcp1 and MFE01 inhibited E.colipUC19
growth (white spots) (Figure 7C). ME01ΔtssC pheno-
type seems similar to a patchwork of MFE01Δhcp1
and MFE01Δhcp2 phenotypes. These results provide an LB in 0.3% agar at 28°C during 24 h. MFE01 and MFE01Δhcp2 were
tative images of mucoidy of MFE01 and MFE01ΔtssC on LB agar at
E01 and its mutants on competitive E.coli on solid medium. Co-cultures
°C during 24 h. Prey cells (E.coli DH5αmcr containing pUC19) were or
is due to X-Gal degradation by E.colipUC19. The images shown are
Table 1 Plasmids and strains used in the study
Strains or plasmids Relevant characteristics Reference/
source
P. fluorescens
MFE01 Air isolate, RifR [31]
MFE01Δhcp2 MFE01 with early stop
codon in hcp2
[31]
MFE01Δhcp1 MFE01 with hcp1 disruption This study




MFE01Δhcp1Δhcp2 MFE01 with hcp1 and hcp2
mutations
This study
MFE01ΔtssC MFE01 with tssC disruption This study
MFN1032 Clinical strain [33]
MFP05 Skin isolate [32]
Pf-5 Plant isolate [34]
MFE07 Air isolate This study
Escherichia coli
DH5αmcr General cloning strain LMSM
collection
S17.1 RP4-2-Tc::Mu, aph::Tn7, recA,








pSMC21-gfp Replicative plasmid, KmR, gfp [46]
pME3087 Suicide plasmid, TcR [47]
pUC19 Replicative plasmid, lacZ, ApR Invitrogen®
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in a T6SS.
Conclusion
In this work, we further illustrate the importance and
versatility of the T6SS in bacterial adaptation and fitness.
We demonstrated cooperation between two different
Hcp proteins in bacterial competition. The observations
indicate that T6SS associated with Hcp1 secretion has
pleiotropic effects on P. fluorescens MFE01: it affects
mucoidy, motility and competitor inhibition in motility
conditions. The relationships between T6SS and flagellin
and between T6SS and mucoidy have not yet been fully
elucidated. Nevertheless, we describe some of the mech-
anisms associated with MFE01 motility and inhibition of
prey cell motility. This suggests that some effectors, that
are used to inhibit competitor motility, could be accu-
mulated in MFE01Δhcp1, in absence of Hcp1, and con-
sequently might inhibit the mutant’s own motility.
Analysis of MFE01 draft genome is under way. Numer-
ous mutants should be constructed to analyse function
of unknown putative genes surrounding these hcp genes
to ensure an informative genomic annotation and to ex-
plain how this T6SS could impact mucoidy and motility.
Methods
Bacterial strains, plasmids and culture conditions
All strains and plasmids used are listed in Table 1. All
bacterial strains were grown in LB medium with shaking
(180 rpm). Pseudomonas fluorescens strains were grown
at 28°C or 37°C and Escherichia coli at 37°C. Media were
supplemented with antibiotics as appropriate: kanamycin
(Km) 50 μg/ml (E. coli) or 200 μg/ml (P. fluorescens);
tetracycline (Tc) 15 μg/ml; gentamicin (Gt) 15 μg/ml
(E. coli), or 50 μg/ml or 100 μg/ml (P. fluorescens in liquid
and solid media, respectively).
Hcp secretion analysis
Hcp secretion was studied by harvesting the superna-
tants by centrifuging the cultures at 5000 × g for 10 mi-
nutes at 20°C and passing them through a Millipore
membrane with 0.22 μm pores. TCA (trichloroacetic
acid, Sigma-Aldrich) was added to the supernatant to a
final concentration of 10% and the mixture was incu-
bated overnight at 4°C. The supernatant was removed by
centrifugation at 13000 × g, for 30 minutes at 4°C. The
protein pellet was washed twice with 5 ml of 20 mM
Tris base (VWR) in cold acetone (Merck) and centri-
fuged at 13000 × g, for 30 minutes at 4°C. The dry pellet
was then resuspended in distilled water. Proteins were
separated by sodium dodecyl sulphate polyacrylamide
gel electrophoresis (SDS-PAGE). Briefly, samples were
mixed with an equal volume of 2 × Laemmli sample buffer(with β-mercaptoethanol), boiled for 5 min at 100°C and
then cooled to room temperature before loading.Mucoid phenotype and swimming assays
Strains were plated on LB agar with 0.1 mM IPTG and
incubated for 24 h at 28°C; the colonies were then exam-
ined for the mucoid phenotype. Swimming assays were
performed as previously described [45].Swarming killing assay
The protocol described by Alteri and colleagues [8]
was used with minor modifications. Aliquots of 5 μl
of a mixture of strains at a ratio of 5:1, MFE01 or
mutants: MFN1032 containing plasmid pSMC21-gfp
[46] were spotted onto LB 0.6% agar with 0.1 mM
IPTG. The plates were incubated overnight at 28°C, and
the entire swarm was collected, and serially diluted. Ali-
quots of 10 μl of each dilution were plated on LB agar
supplemented with 200 μg kanamycin and colony forming
units counted.
Table 2 Oligonucleotides used for this study
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Overnight cultures were centrifuged at 3000 × g, for 5
minutes at room temperature. The cell pellets were
collected on toothpicks which was used to stab 0.3%
agar LB plates, with 0.1 mM IPTG; the plates were then








muta4tssC ATGTCATTGAGATCGGGCAAAntibacterial competition assay
Antibacterial competition assays in solid media were
performed as described by Decoin and coworkers [31].
To ensure pSMC21-gfp stability (presence or absence) in
our conditions, MFN1032 containing pSMC21-gfp was
cultivated in LB medium containing kanamycin until
OD580 nm of 1. Serial dilutions were then plated on LB
plates without Kanamycin during 24 h at 28°C. Colonies
were scrapped and suspended in NaCl 9 g/L and ad-
justed to OD5580 nm of 1. Serial dilutions were plated on
selective (with kanamycin) and non-selective (without
kanamycin) plates and counting. Statistics were done by
pairwise strain comparisons (non-parametric Mann–
Whitney-two tailed Test): no significant difference was
observed between the two conditions (p-value >0.05,
n = 6).
For E.coli growth inhibition, Pseudomonas fluorescens
MFE01 and mutants were cultivated at 28°C in LB
medium with shaking at 180 rpm overnight. Escherichia
coli DH5αmcr transformed with pUC19 (E.colipUC19),
allowing blue detection on medium containing X-Gal,
was cultivated at 37°C in LB with ampicillin (50 μg/ml)
with shaking at 180 rpm overnight. The OD580 nm was
adjusted to 0.5 and the strains were mixed at a 1:1 ratio.
A volume of 20 μl was spotted in LB agar plates supple-
mented with X-Gal (40 μg/ml) and incubated overnight
at 28°C.Disruption of the hcp1 gene in P. fluorescens MFE01
MFE01Δhcp1 was generated by deletions in the 5′
(44 bp) and 3′ extremities (18 bp) of hcp1. 5′ and 3′
truncated hcp1 was generated by PCR with the Hcp3F
and Hcp4R primers (see Table 2). The resulting trun-
cated hcp1 construct was introduced between the
EcoRI and HindIII sites (blunt-ended) of the transfer-
able suicide plasmid pME3087 (6.9 Kb) [47]. The resulting
plasmid, pME3087Δhcp1, was verified by sequencing and
was then transferred into MFE01 by biparental mating:
E. coli S17-1 [48] containing pME3087Δhcp1 and recipi-
ent MFE01 cells were mixed and spotted onto LB agar
plates and incubated overnight at 37°C. The mating
mixture was then suspended in 1 ml of sterile NaCl 9 g/L
and 0.1 ml aliquots were spread on LB agar plates supple-
mented with tetracycline (12 μg/ml), to select for the pres-
ence of the integrated plasmid, and rifampicin (25 μg/ml),
to kill the E. coli S17-1 donor bacteria and to ensure theselection of MFE01. The resulting hcp1 mutant (contain-
ing two truncated hcp1 genes) was named MFE01Δhcp1.
Disruption of the hcp2 gene in P. fluorescens MFE01Δhcp1
and disruption of the tssC gene in P. fluorescens MFE01
A markerless hcp2 mutation was introduced into
MFE01Δhcp1 strain by the protocol described by Decoin
and co-workers [31]. The resulting strain was named
MFE01Δhcp1Δhcp2. The same protocol with PCR modifi-
cations was used to introduce a markerless tssC mutation
into MFE01 strain. This tssC deletion was achieved by
PCR with the muta1tssC and muta2tssC primers (<650 bp
product) or the muta3tssC and muta4tssC primers (<650
bp product) (Table 2). The PCR products obtained cor-
responded to the upstream and downstream parts, re-
spectively, of the tssC gene of MFE01, each carrying an
overlapping sequence at the end. PCR parameters were as
follows: annealing temperature, 62°C, extension time, 45 s;
35 cycles. A third PCR was then carried out in which the
overlapping sequences of the two first products were hy-
bridized together allowing the tssC deletion after PCR
with the muta1tssC and muta4tssC primers. The PCR
parameters were as follows: annealing temperature, 62°C;
extension time, 1 m 45 s and 35 cycles. The mutant con-
taining the tssC deletion was verified by DNA sequencing
and named MFE01ΔtssC.
Heterologous expression of mucA in MFE01
The mucA (PFL_1449) sequence was amplified with the
PFL_1449mucAF and PFL_1449mucAR primers (Table 2)
by standard PCR from genomic DNA from P. protegens
Pf-5. The PCR conditions were as follows: an annealing
temperature of 64°C, an extension time of 30 s and 25
cycles. The polymerase used was Phusion® High-Fidelity
DNA polymerase (NEB). The PCR product was digested
with SacI (NEB) and XbaI (NEB) and ligated into
pPSV35 [49] digested with the same enzymes. E. coli was
Decoin et al. BMC Microbiology  (2015) 15:72 Page 10 of 12transformed with the ligation product and the resulting
plasmid was checked by PCR. Fresh MFE01 colonies
were washed twice in cold sterile distilled water and
transformed with 5 μl of plasmid DNA by electropor-
ation in 1 mm cuvette at 1.8 kV (Savant electroporater).
LB was then added and the mix incubated for 1 h at 28°C
with shaking (180 rpm). The samples were then plated on
LB agar supplemented with gentamicin and with 0.1
mM IPTG.
Insertion of the hcp1 gene into pPSV35 and construction
of strain MFE01Δhcp1+hcp1
The hcp1 gene was amplified from the P. fluorescens
MFE01 genome with the Hcp1F and Hcp2R primers
(Table 2). The PCR conditions were as follows: an an-
nealing temperature of 59°C, an extension time of 30 s
and 25 cycles. The polymerase used was the Phusion®
High-Fidelity DNA polymerase (NEB). The amplified
fragments were inserted into the pPSV35 shuttle vector
at SmaI site by blunt-end ligation, and the resulting
pPSV35-hcp1 was used to transform E. coli DH5αmcr
cells by electroporation. Plasmid DNA was isolated using
the QIAprep Spin Miniprep Kit (Qiagen) and checked
by PCR and asymmetric digestion with BamHI (NEB) to
verify the orientation of the insert. MFE01Δhcp1 was
transformed with pPSV35-hcp1 by electroporation as
described in the section “Heterologous expression of
mucA in MFE01”. The resulting strain was called
MFE01Δhcp1+hcp1.
Preparation and purification of extracellular matrix (ECM)
containing exopolysaccharides (EPS)
Strains were tested for EPS production on LB agar at
28°C. ECM was extracted as described by Dignac and
colleagues with modifications [50]. Biomass was harvested
and suspended in NaCl 9 g/L then sonicated at 37 Watts
for 30 sec on ice and centrifuged (20,000 × g for 30 min).
Clear supernatants were collected and three volumes of
ice-cold ethanol were added; the samples were incubated
for 24 h at 4°C, and EPS were collected by centrifuga-
tion (7000 × g, 30 min). The EPS-containing pellets were
resuspended in water and lyophilised.
Analysis of the monosaccharide composition of EPS by
gas chromatography – flame ionization
Lyophilised EPS were hydrolysed by treatment with 2M
trifluoroacetic acid for 2 hours at 110°C. Monosaccha-
rides were then derivatised: methanol-1M HCl (Supelco)
was added and the samples incubated at 80°C overnight;
then a mix of hexamethyldisiloxan:trimethyldisiloxan:
pyridine (3:1:9, Supelco) was added and the samples in-
cubated at 110°C for 20 minutes. The resulting deriva-
tives were dried then dissolved in 1 ml of cyclohexane
and injected into the 3800 GC system equipped with aCP-Sil5-CB column (Agilent Technologies). Elution was
performed with the following gradient of temperature:
120°C to 160°C at a rate of 10°C per minute, 160°C to
220°C at a rate of 1.5°C per minute, 220°C to 280°C at a
rate of 20°C per minute. Quantification was based on
the internal standard and response factor determined
previously for each monosaccharide.Biofilm formation
Pure culture biofilms were grown in continuous-culture
three-channel flow cells (channel dimensions, 1 by 4 by
40 mm). The system was assembled and prepared as fol-
lows: system sterilization during 4 h with bleach at 1.2%
and rinsing with sterile NaCl 9 g/L. Before flow chamber
inoculation, LB medium was injected into the system at
28°C. Overnight cultures were centrifuged at 8 000 × g
during 5 min at room temperature. Pellets were recov-
ered and washed twice with 2 mL of sterilized physio-
logical water. Channels were inoculated with 1 mL of
pure bacterial suspension at DO580nm = 0.1. Bacteria
were allowed to attach to the glass surface (microscope
coverslip, VWR International, Fontenay sous Bois, France)
during 2 h at 28°C under static conditions. Biofilm growth
was then performed under a constant flow of LB medium
with antibiotics at appropriate concentration if necessary
(Wakson Marlow 205S, 2.5 mL/h) for 48 h at 28°C.Confocal laser scanning microscopy (CLSM) and image
analyses
Microscopic observations were performed with a LSM
710 system, Zeiss, Germany by using a 63x oil immersion
objective. Biofilms were observed after a 15 min incuba-
tion with 5 μM Syto 9® green fluorescent nucleic acid stain
(life technologies) (excitation and emission λ, 488 nm and
510 nm, respectively). Biofilm stacks were analysed with
COMSTAT software. The calculated parameter was the
biovolume, which is the volume of bacteria (in μm3) per
μm2 of glass surface. The results were the mean of at least
five independent experiments.Mass spectrometry analysis
Mass spectroscopy (MS) analyses were performed with a
MALDI-TOF AutoflexIII (Brucker) in positive ion mode
as described by Barbey et al. [51]. Statistical analyses
of the sequences involved determining the probability
based on Mowse score with MASCOT software (pep-
tide tolerance = 100 ppm and mass values =MH+). A
p-value of less than 0.05 was considered significant.
The criteria used to accept a protein identification based
on peptide mass fingerprinting (PMF) data included a
score probability greater than a score threshold defined by
MASCOT software.
Decoin et al. BMC Microbiology  (2015) 15:72 Page 11 of 12Statistical analysis
Non-parametric Mann–Whitney Tests (two tailed) with
GraphPad Prism version 6.0 (La Jolla, CA) were used for
statistical analyses. A p-value <0.05 was considered to be
statistically significant.
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